Pneumonia Flashcards
Clinical conditions with MRSA (Harrison pp 803)
- Hospiitalization ≥ 48 hours
- Hospitalization ≥2 days in prior 3 months
- Nursing homes
- Chronic dialysis
- Home infusion therapy
- Home wound care
- Family members with MDR
Clinical conditions with pseudomonas aeruginosa and MDR enterobacteriacea (Harrison pp 803)
- Hospitalization ≥ 48 hours
- Hospitalization ≥2 hours in preceding 3 months
- Nursing homes
- Antibiotics therapy in preceding 3 months
Proliferation of microbial pathogens at alveolar level and the host response to pathogen (Harrison pp 804)
Pneumonia
Most common etiology of pneumonia (Harrison pp 804)
aspiration from the oropharynx
Mechanical factors involved in pnuemonia (Harrison pp 804)
Gag reflex and cough mechanism
Initiate the inflammatory response (Harrison pp 804)
Macrophage
Inflammatory mediators for fever (Harrison pp 804)
Interlukin 1 and TNF
Stimulate release of neutrophils that increases purulent secretions (Harrison pp 804)
Interlukin 8 and granulocyte colony-stimulating
Pathologic phases of pneumonia (Harrison pp 804)
Edema
Red hepatization phase
Gray hepatization phase
Resolution
Most common in nosocomial pneumonia pattern (Harrison pp 804)
Bronchopneumonia pattern
Alveolar pattern (Harrison pp 804)
Pneumocystis pneumonia
Most common etiologic agent with CAP (Harrison pp 804)
Streptococcus pneumoniae
Atypical bacteria (Harrison pp 804)
L egionella species
C hlamydia pneumoniae
M ycoplasma pneumoniae
Common etiology for CAP Outpatient (Harrison pp 804)
Streptococcus pneumoniae Chlamydia pneumoniae Mycoplasma pneumoniae Haemophillus influenzae Respiratory viruses
Common etiology for CAP Non-ICU (Harrison pp 804)
Streptoccus pneumoniae Mycoplasma pnuemoniae Chlamydia pneumoniae Haemophilus influenzae Respiratory viruses Legionella spp.
Common etiology for CAP-ICU (Harrison pp 804)
Streptoccus pneumoniae Staphyloccos aureus Legionella sp Gram negative Haemophilus influenzae
Staphylococcus pneumoniae common etiology for CAP Non-ICU (Harrison pp 805)
Necrotizing pneumonia
Alcoholism (Harrison pp 805)
S treptoccus pneumoniae O ral anaerobes K lebsiella pneumoniae A cinetobacter spp M ycobacterium tuberculosis
COPD/Smoking (Harrison pp 805)
Haemophilus influenza Pseudomonas aeruginosa Legionella spp Moraxella catarrhalis Chlamydia penumonias
Dementia, stroke, decrease level of consciousness (Harrison pp 805)
GO
Gram negative
Oral anaerobes
Lung abscess (Harrison pp 805)
CAP-MRSA Oral anaerobes Endemic fungi Mycoplasma tuberculosis Atypical mycobacterium
Exposure to birds (Harrison pp 805)
Chlamydia psitacci
Exposure to rabbits (Harrison pp 805)
Francisella tularensii
Exposure to sheep, goats, parturients cats (Harrison pp 805)
Coxiella burnetii
Risk factors for pneumococcal pneumonia (Harrison pp 805)
Dementia Seizure disorder Heart Failure Cerebrovascular disease Alcoholism Tobacco smoking COPD HIV infection
Risk factor for Legionella (Harrison pp 805)
Diabetes Hematologic malignancy Cancer Severe renal disease HIV Smoking Male Gender Recent hotel stay or ship cruise
Sputum culture (Harrison pp 806)
> 25 neutrophils, < 10 squamous epithelial cells per low power fields
Only ≤ 50% is positive
Blood culture (Harrison pp 806)
5-14% gets positive
High risk patient with CAP that should have blood culture done (Harrison pp 806)
CANS Complement deficiencies Chronic Liver Disease Asplenia Neutropenia sec to pneumonia Severe CAP
(+) PCR is associated with the following: (Harrison pp 806)
Sadist, Masochist leads to Death
Septic Shock
Mechanical
Death
How high should IgM rise to be considered diagnostics? (Harrison pp 806)
4X
Identification of worsening disease or treatment failure (Harrison pp 806)
CRP
Need for antibacterial therapy (Harrison pp 806)
PCT
Prognostic model used to identify patient at low risk of dying (Harrison pp 806)
Pneumonia Index Severity (PSI)
Class 1 and 2: Dec rates of admission
Class 3: admission
Severity of illness scoring with CAP (Harrison pp 806)
CURB 65 Criteria
Confusion Urea > 7mmol/L Respiratory rate ≥ 30 breaths/min Blood pressure ≤ SBP 90 and ≤ DBP 60 Age ≥ 65 years old
Risk factors for early deterioration of CAP (Harrison pp 807)
Multilobar infiltrates Severe hypoxemia (<90%) Severe acidosis (<7.30) Mental confusion Severe tachypnea (>30 breaths/min) Hypoalbuminemia Neutropenia Thrombocytopenia Hyponatremia Hypoglycemia
Risk factors for penicillin-resistant pneumococcal infection (Harrison pp 807)
Recent antimicrobial therapy Age < 2 years or > 65 years Attendance at day care center Recent hospitalization HIV infection
Drug of choice for enterobacteriae species (CAP) (Harrison pp 807)
Fluoroquinolones or Carbapenems
CAP-MRSA superantigens (Harrison pp 807)
Enterotoxin B
Enterotoxin C
Panton-Valentine leukocidin
Antibiotics of choice for Outpatient CAP that is healthy and no antibiotics use for 3 months (Harrison pp 808)
Macrolides (Azithromycin 500mg OD, Clarithromycin 500mg BID)
Doxcycycline 100mg BID
Antibiotics of choice for Outpatient CAP that is comorbidities and recent antibiotics use (Harrison pp 808)
Respiratory fluoroquinolones (Moxifloxacin 400mg OD, gemifloxacin 320mg OD, and levofloxacin 750 mg OD) Beta lactam (Amoxicillin 1g TID or Amox-Clav 2g BID)
Antibiotics of choice for Inpatient NON-ICU (Harrison pp 808)
Respiratory fluoroquinolones (Moxifloxacin 400mg OD or Levoxfloxacin 750mg OD) Beta lactam (Ceftriaxone 2g IV OD, ampicillin 2g IV q6) + macrolide (Clarithromycin or azithromycin)
Antibiotics of choice for Inpatient ICU (Harrison pp 808)
Beta-lactam + azithromycin or fluoroquinolones
Antibiotics of choice for pseudomonas (Harrison pp 808)
Antipseudomonal Beta lactam ( pipercillin tazobactam 4.5 g q6, cefepime 2g q12, imipenem 500mg q6)
Beta-lactam plus aminoglycosides (amikacin 15mg/kg qd) plus azithromycin
Antibiotics of choice for CAP-MRSA (Harrison pp 808)
Linezolid 600mg q12
Vancomycin 15mg/kg q12
Complications of CAP (Harrison pp 808)
Metastatic infection
Lung abscess
Aspiration pneumonia
Main preventive measure in CAP (Harrison pp 809)
Vaccination
Major risk factor for MDR pathogens (Harrison pp 809)
Recent hospitalization
What is the greatest difference of VAP and HCAP/HAP studies? (Harrison pp 809)
Expectorated sputum for a diagnosis of VAP
What are MDR pathogens causes of ventilator-associated pneumonia? (Harrison pp 809)
Pseudomonas aerigunosa MRSA Acinetobactor spp. Antibiotic-resistant Enterobacteriaceae (Enterobacter spp, ESBL +, Klebsiella pneumoniae) Legionella pneumophila Burkholderia cepacia Aspergillus spp.
Three factors critical in the pathogenesis of VAP (Harrison pp 810)
colonization–> aspiration –> compromising the normal flora
Most obvious risk factor for VAP (Harrison pp 810)
Endotracheal tube
What is the major complication of VAP? (Harrison pp 812)
Prolongation of mechanical ventilator
What is the major risk factor for primary lung abscess? (Harrison pp 813)
Aspiration
Patient that are risk for aspiration are the following: (Harrison pp 813)
Altered mental status Alcoholism Drug overdose Seizures Bulbar dysfunction Prior cerebrovascular or cardiovascular or neuromuscular disease
Infection of Fusobacterium necrophorum (pharynx)–> neck and carotid sheath and cause septic thrombophlebitis (Harrison pp 814)
Lemierre’s syndrome
What is the treatment of choice for primary lung abscesses? (Harrison pp 815)
Clindamycin 600mg/IV 3x/day –> 300mg PO 4x/day
IV administered B-lactam/B-lactamase
for 3-4 weeks for weeks
Definition of lung abscess (Harrison pp 813)
Necrosis and cavitation
> 2cm in diameter
What size of abscess is considered less likely to respond to antibiotic therapy? (Harrison pp 815)
> 6-8 cm in diameter
What are the poor prognostic factors associated with lung abscess? (Harrison pp 815)
age > 60 year old presence of aerobic bacteria sepsis at presentation symptom duration of > 8 weeks abscess size > 6 cm